Adage Capital Partners
VAXX

Adage Capital Partners’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Adage Capital Partners’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000,000
Closed -$2.15M – 970
2024
Q1 		$2.15M Hold
3,000,000
– – ﹤0.01% 771
2023
Q4 		$2.55M Hold
3,000,000
– – 0.01% 731
2023
Q3 		$4.11M Hold
3,000,000
– – 0.01% 685
2023
Q2 		$7.56M Hold
3,000,000
– – 0.02% 618
2023
Q1 		$6.81M Buy
3,000,000
+1,998,330
+199% +$5.07M 0.02% 675
2022
Q4 		$1.4M Hold
1,001,670
– – ﹤0.01% 829
2022
Q3 		$1.98M Hold
1,001,670
– – ﹤0.01% 855
2022
Q2 		$1.57M Hold
1,001,670
– – ﹤0.01% 893
2022
Q1 		$4.31M Hold
1,001,670
– – 0.01% 845
2021
Q4 		$5.62M Buy
+1,001,670
New +$10.4M 0.01% 804

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Adage Capital Partners's VAXX Position: Q2 2024 in Review

Adage Capital Partners sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 3,000,000 shares — an estimated $2.15M sold.

Adage Capital Partners first reported a position in VAXX in Q4 2021 and held it in 10 quarters. The position peaked at $7.56M in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Adage Capital Partners reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Adage Capital Partners sold 3,000,000 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $2.15M.
  • Adage Capital Partners first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 10 quarters.
  • Adage Capital Partners's Vaxxinity, Inc. Class A Common Stock position peaked at $7.56M in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Adage Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.